Knowledge Hub

Global Human Immunodeficiency Virus (HIV) Infections (AIDS) Industry Trends, Size, Drivers, Strategies, Products Clinical Trials Review, H2, 2016

Press release   •   Nov 29, 2016 05:36 EST

GlobalData's clinical trial report, Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Review, H2, 2016" provides an overview of Human Immunodeficiency Virus (HIV) Infections (AIDS) clinical trials scenario. This report provides top line data relating to the clinical trials on Human Immunodeficiency Virus (HIV) Infections (AIDS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

View Report At


- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Download Sample copy of this Report at :

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Human Immunodeficiency Virus (HIV) Infections (AIDS) to Infectious Disease Clinical Trials 15

Clinical Trials by Phase in G7 Countries 17

Clinical Trials in G7 Countries by Trial Status 18

Clinical Trials by E7 Countries: Proportion of Human Immunodeficiency Virus (HIV) Infections (AIDS) to Infectious Disease Clinical Trials 19

Clinical Trials by Phase in E7 Countries 21

Clinical Trials in E7 Countries by Trial Status 22

Clinical Trials by Phase 23

In Progress Trials by Phase 24

Clinical Trials by Trial Status 25

Clinical Trials by End Point Status 26

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials 30

Prominent Drugs 32

Latest Clinical Trials News on Human Immunodeficiency Virus (HIV) Infections (AIDS) 33

Oct 06, 2016: CytoDyn Announces Favorable Protocol Modifications for Pivotal Phase 3 Combination Trial With PRO 140 After Positive FDA Meeting 33

Sep 13, 2016: ABIVAX Completes the Second Milestone in CaReNa, a Strategic Industrial Innovation Project Supported by Bpifrance 33

Aug 23, 2016: Patients Approach Two Years of Complete HIV Viral Load Suppression in Phase 2b PRO 140 Monotherapy Extension Study 34

Aug 18, 2016: Ibalizumab Phase III Study Primary End-Point Results to Be Presented at IDWeek 2016 35

Aug 16, 2016: ViiV Healthcare launches phase III programme evaluating a two-drug regimen combining dolutegravir and lamivudine for HIV-1 treatment 35

Jul 26, 2016: SMILE Trial Launch - investigating a potentially lower toxicity, simplified treatment regimen for HIV infected children 35

Clinical Trial Profile Snapshots 36

Appendix 2794

Abbreviations 2794

Definitions 2794

Research Methodology 2795

Secondary Research 2795

About GlobalData 2796

Contact Us 2796

Disclaimer 2796

Source 2797 is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.